Go Xeno-Free: Rice-Derived rHSA for Bioprocess Consistency

Human serum albumin (HSA) is the most abundant protein in human plasma. Its primary role is to bind and transport a wide range of endogenous molecules, including fatty acids, hormones, and lipids, while helping maintain plasma oncotic pressure. These functions are supported by HSA’s ability to bind diverse compounds and its high solubility and stability across a broad pH range. Together with its non-toxicity, non-enzymatic activity, non-immunogenicity and anti-oxidation properties, these characteristics make HSA useful in pharmaceutical formulations and biotechnology applications, including as a stabilizing or blocking reagent. 
 
Traditionally, HSA has been isolated from donated human plasma. However, plasma is a limited resource, and demand for HSA in biopharmaceutical applications continues to grow. Plasma-derived products may also raise concerns about pathogen transmission and can vary between batches. The recombinant human serum albumin (rHSA) provides an alternative source that can help address supply constraints and improve batch consistency. These advantages have increased interest in rHSA for pharmaceutical and laboratory applications, including its use as a blocking reagent. 

Applications of Recombinant HSA

OsrHSA, a recombinant human serum albumin expressed by rice endosperm platform, provides an excellent solution for animal free material. Compared to FBS, pHSA and BSA. OsrHSA has higher purity and excellent batch consistency. Meanwhile, OsrHSA is widely used as excipient, stabilizer and embedding agent in bio-pharmaceutical applications. The rice endosperm platform makes the manufacture capability at hundreds of kilograms scales. 

Unlocking Superior Versatility: 
The Broad Applications of OsrHSA 

The OsrHSA has emerged as a high-performance, animal-free standard across a vast range of biotechnological and biopharmaceutical applications—including viral vector manufacturing, stem cell therapy, diagnostics, medical devices, and formulation stabilization. To provide a clear, real-world look at this superior performance in action, here are a few concrete application examples and data highlights—starting with its remarkable impact on gene delivery efficiency.

a. Boosting AAV Transduction: OsrHSA Significantly Enhances Infection Efficiency

Achieving high transduction efficiency is critical for successful AAV-based workflows. Quantitative evaluation demonstrates that pre-incubating AAV9 with OsrHSA dramatically improves infection efficiency in 293T cells in a clear, dose-dependent manner. Measured via luciferase reporter activity, adding OsrHSA consistently increases expression levels across both high and low viral MOIs, delivering up to a 3-fold enhancement in luci signal compared to untreated controls and reaching an optimal performance plateau at 1%-2% concentration. 

b. Optimizing IVD Assays: OsrHSA Delivers Superior Low Matrix Background

In In Vitro Diagnostics (IVD), selecting the right protein matrix for calibrators and controls is essential to minimize non-specific binding and ensure high signal-to-noise ratios. In a chemiluminescence project assessing matrix background performance, OsrHSA demonstrated a distinct advantage over conventional blockers. Measured by Relative Light Units (RLU), OsrHSA from different lots consistently yielded significantly lower baseline background noise compared to BSA and native serum. By delivering a cleaner background profile, OsrHSA enhances analytical sensitivity and reliability across critical diagnostic assays. 

c. Supporting iPSC Maintenance: OsrHSA Enhances Cell Viability and Culture Stability  

In human induced pluripotent stem cell (iPSC) expansion, maintaining high cell viability and culture consistency is essential for robust downstream manufacturing. When evaluated alongside yeast-derived recombinant human serum albumin, rice-derived OsrHSA demonstrated superior performance in supporting iPSC cultures. Evaluation across colony morphology, alkaline phosphatase (ALP) staining, and immunofluorescent staining of pluripotency markers (Nanog and Oct3/4) confirms that OsrHSA is more effective at preserving the undifferentiated state and maintaining high cell viability. By offering a highly consistent, xeno-free matrix environment, OsrHSA helps minimize culture stress and prevent spontaneous differentiation, serving as a reliable supplement for regenerative medicine workflows. 

Ultimately, rice-derived recombinant human serum albumin (OsrHSA) stands out as a versatile, high-performance, and ultra-pure recombinant protein standard across a wide range of biopharmaceutical and biotechnology applications. By offering a 100% xeno-free matrix, it eliminates the risks of blood-borne pathogen contamination, guarantees batch-to-batch consistency, and significantly streamlines regulatory compliance as you transition from discovery to commercial production.

ScienCell Research Laboratories is dedicated to being your trusted, long-term supply chain partner for high-grade OsrHSA. To support various research scales and commercial workflows, we maintain robust, ready-to-ship inventory in multiple standard sizes:

• Flexible In-Stock Sizes: Available in 1g, 10g, 50g, and 100g pack sizes for immediate dispatch.
• Cost-Effective Scalability: Highly competitive pricing with attractive volume discounts on bulk orders.
• Reliable Quality & Batch Security: Strict quality control ensures high purity, ultra-low endotoxin levels, and reproducible performance from tube to tank.

Whether you are optimizing upstream formulations or scaling up diagnostic production, our technical team is ready to assist. Contact ScienCell today to get a customized quote or discuss tailored bulk supply agreements!